Label schedules
Tirzepatide dose schedule
Tirzepatide is sold as Mounjaro and Zepbound, and both labels describe once-weekly injections. Their shared active ingredient does not erase differences in indications or in the wording around escalation. This dose schedule places the adult label references together while keeping their conditions visible. Labeled tirzepatide vials hold ready-to-use solution: single-dose vials contain 2.5 to 15 mg in 0.5 mL, and multi-dose vials give four 0.6 mL doses. Mounjaro labelZepbound label
Updated . Last editorial review by The PinPoint team
What is the tirzepatide dose schedule?
The Mounjaro and Zepbound labels both start at 2.5 mg once weekly, with 2.5 mg steps after at least four weeks on the current dose, up to 15 mg once weekly in adults. Zepbound increases to 5 mg after the first four weeks. Mounjaro increases only if additional glycemic control is needed.
What does the Zepbound label schedule say?
Zepbound begins with 2.5 mg weekly for four weeks, followed by 5 mg weekly. Further changes use 2.5 mg increments after at least four weeks at the current amount. In weight management, maintenance doses are 5, 10, or 15 mg weekly. In obstructive sleep apnea, the label lists 10 or 15 mg weekly. The 2.5 mg initiation amount is not a maintenance dose. Zepbound label
The longer a reference table becomes, the easier it is to read it as a mandatory ladder. That is why this table describes later stages as conditional instead of assigning every reader a fixed week for reaching 15 mg. It retains the difference between a minimum interval, a prescribed change, and an ongoing maintenance phase. Those are separate pieces of information.
| Timing (weeks) | Amount | Label context |
|---|---|---|
| 1–4 | 2.5 mg weekly | Initiation |
| 5 onward | 5 mg weekly | After the initial four weeks |
| Later, if prescribed | 7.5, 10, 12.5, then 15 mg weekly | At least four weeks at each current dose; 2.5 mg steps |
What does the Mounjaro label schedule say?
The current Mounjaro label starts at 2.5 mg weekly and describes increases of 2.5 mg after at least four weeks at the current dose when additional glycemic control is needed. The maximum weekly amount is 15 mg in adults. Its pediatric maximum is different, so the table below is explicitly limited to the adult reference. Product-specific instructions remain important even when the milligram strengths overlap. Mounjaro label
| Timing | Amount or increment | Condition |
|---|---|---|
| Starting phase | 2.5 mg weekly | Current label initial amount |
| After at least 4 weeks at current dose | Increase by 2.5 mg if additional glycemic control is needed | Prescriber-directed timing |
| Later stages, if prescribed | 5, 7.5, 10, 12.5, 15 mg weekly | Adult maximum: 15 mg weekly |
Why can't the schedule be written in syringe units?
A dose expressed in milligrams does not imply one universal syringe marking. For arithmetic only: at a concentration of 5 mg/mL printed on a vial, 0.20 mL contains 1 mg; at 2.5 mg/mL the same 0.20 mL contains 0.5 mg.
These examples are numerical illustrations, not preparation instructions or approved-product concentrations; no labeled tirzepatide product is reconstituted. A prescribed pen or labeled vial follows its own label. The units reference and tirzepatide calculator keep the calculation separate from the choice of a clinical dose. A result can be arithmetically correct while its inputs describe the wrong container, which is why identifying the actual concentration comes before interpreting the output.
What is the half-life of tirzepatide?
The Mounjaro prescribing information gives an elimination half-life of approximately five days after subcutaneous administration. The decay table below uses that value, 120 hours (5 days); it is not a measurement of anyone's levels or of how long an effect lasts. Mounjaro label
The five-day reference is shorter than the seven-day dosing interval. As a result, a weekly marker falls between the first and second half-life, rather than at the 50% point. A calendar week and a half-life answer different questions. One describes time between entries; the other controls the slope of this simplified decline. The label source is population information, not a measurement of the reader. Mounjaro label
Starting at an arbitrary 100%, each elapsed half-life divides the remaining modeled amount by two. The table describes a single contribution with no further entries, and its percentages are not percentages of benefit or activity. Five half-lives, 600 hours or 25 days, leave 3.125% of that one contribution; exponential decay never reaches exactly zero, and the figure is not a detection window or a washout instruction.
| Half-lives | Hours | Days | Remaining (rounded) |
|---|---|---|---|
| 0 | 0 | 0 | 100.0% |
| 1 | 120 | 5 | 50.0% |
| 2 | 240 | 10 | 25.0% |
| 3 | 360 | 15 | 12.5% |
| 4 | 480 | 20 | 6.3% |
What the label's once-weekly schedule means mathematically: in an equal-input model, the limiting peak accumulation ratio is 1 ÷ (1 − 2 raised to minus interval divided by half-life). It compares a repeated pattern with one instantaneous input and assumes the same interval continues indefinitely. Mounjaro label
- Once weekly, if evenly spaced: 168 hours between entries; 37.89% of one contribution remains at that marker; limiting accumulation ratio 1.61. Mounjaro label
The Mounjaro label states that steady-state concentrations were reached after 4 weeks of once-weekly dosing. Changing amounts, missed entries, irregular spacing and absorption change the pattern. The calculation does not decide when to start, stop, or change anything. Mounjaro label
What do the tirzepatide labels say about a missed dose?
Both labels give the same rule. Take the missed dose "as soon as possible within 4 days (96 hours) after the missed dose." If more than 4 days have passed, "skip the missed dose and administer the next dose on the regularly scheduled day." Both labels add that the regular once-weekly schedule then resumes, and that the weekly day can be changed if the two doses are at least 3 days (72 hours) apart. Mounjaro labelZepbound label
| Time since the scheduled dose | What both labels say |
|---|---|
| Up to 4 days (96 hours) | Take the missed dose as soon as possible |
| More than 4 days | Skip it and take the next dose on the usual day |
How do you log a late dose, or a change of dose, in PinPoint?
Log the dose at the time you actually took it, not the time it was planned. PinPoint lets you backfill an entry, so a dose planned for Thursday and taken on Saturday sits on Saturday in the history. The gap between doses then stays visible when you, or your prescriber, look back at the record. App features
PinPoint supports titration phases for step-ups and step-downs, along with weekly reminders, a calendar, and backfilled dose entries. Injection logs can include the compound, amount, site, and pain level. That structure can preserve the history of an earlier phase while the entered plan reflects a later one. Notes and side-effect severity entries offer space for dated observations alongside the injection record. App features
The supply forecast concerns remaining vials or pens. The modeled-level curve is an estimate from the half-life value stored for each compound, published where a published value exists and an estimate where none does. Neither feature decides a maintenance amount or confirms an individual blood level. Keeping the source schedule, personal prescription, actual dose history, and app model distinct makes a review of the record easier to follow. App features
Useful distinctions
Questions
What is the shortest interval between escalation steps in these references?
The labels describe at least four weeks at the current dose before later increases. Zepbound directs the change from 2.5 mg to 5 mg after 4 weeks. Later increases on either label come after at least 4 weeks at the current dose and are not required. Zepbound labelMounjaro label
Are 20 units a tirzepatide dose?
Twenty U-100 units is 0.20 mL. The milligram amount depends on the solution concentration, so the syringe marking alone cannot answer the dose question.
Is the half-life of Tirzepatide the same for everyone?
The Mounjaro label gives an elimination half-life of approximately 5 days and the Zepbound label approximately 5 to 6 days in people with overweight or obesity. The Mounjaro label states that age, gender, race, ethnicity and body weight have no clinically relevant effect on tirzepatide pharmacokinetics. Mounjaro labelZepbound label
What do five half-lives mean?
The label gives an elimination half-life of approximately 5 days and states no clearance time. Five half-lives of 5 days is 25 days. Mounjaro label
What does steady state mean?
For unchanged, equally spaced inputs in a linear model, steady state means the pattern repeats from one interval to the next. About five half-lives gives roughly 97% of the limiting pattern. Peaks and troughs still occur; steady state does not mean a flat line or a recommended regimen.
Your record, together
Keep the details attached to the date.
Dose history, reminders, daily notes, and the context you choose to record. PinPoint app features.
Get PinPoint on the App StoreSources & scope
Label facts link to the full prescribing information. Product claims use the supplied PinPoint app description. Numerical examples show their assumptions and arithmetic.
- PinPoint feature description
Only feature claims verified against the supplied description. No prices, clinical recommendations or inferred tablet inventory.
- Mounjaro prescribing information
2 (schedule/administration), 3 (presentations), 6.1–6.2 (adverse reactions), 14 (study identity), Medication Guide and Instructions for Use. DailyMed set ID:
d2d7da5d-ad07-4228-955f-cf7e355c8cc0, DailyMed SPL of 27 August 2026. - Zepbound prescribing information
2 (schedule/administration), 3 (presentations), 6.1–6.2 (adverse reactions), 14 (study identity), Medication Guide and Instructions for Use. DailyMed set ID:
487cd7e7-434c-4925-99fa-aa80b1cc776b, DailyMed SPL of 28 August 2026.